Drug class
Butyrophenone antipsychotic; dopamine D2 receptor antagonist
Mechanism of action
Antagonises central dopamine D2 receptors, reducing dopaminergic neurotransmission in pathways associated with psychosis. It also has alpha-adrenergic and other receptor effects.
General use cases
- Treatment of schizophrenia and other psychotic disorders in countries where benperidol remains authorised; historical use and current availability are jurisdiction-specific
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
